News Releases

Date Title
11/20/18
Summary ToggleHeron Therapeutics to Present at the Evercore ISI HealthCONx Conference Printer Friendly Version
11/12/18
Summary ToggleU.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics Printer Friendly Version
11/07/18
Summary ToggleHeron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress Printer Friendly Version
10/31/18
Summary ToggleHeron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management Printer Friendly Version
09/24/18
Summary ToggleHeron Therapeutics to Present at the 2018 Cantor Global Healthcare Conference Printer Friendly Version
08/08/18
Summary ToggleHeron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress Printer Friendly Version
06/25/18
Summary ToggleHeron Therapeutics Announces Pricing of Public Offering of Common Stock Printer Friendly Version
06/25/18
Summary ToggleHeron Therapeutics Announces Public Offering of Common Stock Printer Friendly Version
06/21/18
Summary ToggleHTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA Printer Friendly Version
06/21/18
Summary ToggleHeron Announces Positive Topline Results from Phase 2b Clinical Studies of HTX-011 in Total Knee Arthroplasty and Breast Augmentation Printer Friendly Version
05/29/18
Summary ToggleHeron Therapeutics to Present at the Jefferies 2018 Healthcare Conference Printer Friendly Version
05/10/18
Summary ToggleHeron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress Printer Friendly Version
05/09/18
Summary ToggleHeron Therapeutics to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference Printer Friendly Version
03/28/18
Summary ToggleHeron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock Printer Friendly Version
03/28/18
Summary ToggleHeron Therapeutics Announces Proposed Public Offering of Common Stock Printer Friendly Version
03/21/18
Summary ToggleHeron Therapeutics to Present at the 17th Annual Needham Healthcare Conference Printer Friendly Version
03/19/18
Summary ToggleHeron Announces Positive Topline Results From Pivotal Phase 3 Clinical Trials of HTX-011 in Bunionectomy and Hernia Repair Printer Friendly Version
03/06/18
Summary ToggleHeron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference Printer Friendly Version
02/27/18
Summary ToggleHeron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress Printer Friendly Version
02/12/18
Summary ToggleHeron Therapeutics to Present at the 7th Annual Leerink Partners Global Healthcare Conference Printer Friendly Version
01/08/18
Summary ToggleHeron Therapeutics Highlights Progress in CINV and Pain Management Franchises Printer Friendly Version
01/02/18
Summary ToggleHeron Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference Printer Friendly Version